Healthcare and Medicine Reference
In-Depth Information
122. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Sleep dura-
tion as a risk factor for diabetes incidence in a large U.S. sample.
Sleep 2007;30:1667-1673.
123. Hayashino Y, Fukuhara S, Suzukamo Y, et al. Relation between
sleep quality and quantity, quality of life, and risk of developing
diabetes in healthy workers in Japan: the High-risk and Population
Strategy for Occupational Health Promotion (HIPOP-OHP)
Study. BMC Public Health 2007;7:129.
124. Cappuccio FP, Taggart FM, Kandala NB, et al. Meta-analysis of
short sleep duration and obesity in children and adults. Sleep
125. Chen X, Beydoun MA, Wang Y. Is sleep duration associated with
childhood obesity? A systematic review and meta-analysis. Obesity
(Silver Spring) 2008;16:265-274.
126. Patel SR, Hu FB. Short sleep duration and weight gain: a systematic
review. Obesity (Silver Spring) 2008;16:643-653.
127. Patel SR, Blackwell T, Redline S, et al. The association between
sleep duration and obesity in older adults. Int J Obes (Lond)
128. Van Cauter E, Knutson K. Sleep and the epidemic of obesity in
children and adults. Eur J Endocrinol 2008;159:S59-S66.
129. Berkey CS, Rockett HR, Colditz GA. Weight gain in older adoles-
cent females: the internet, sleep, coffee, and alcohol. J Pediatr
130. Keith SW, Redden DT, Katzmarzyk PT, et al. Putative contributors
to the secular increase in obesity: exploring the roads less traveled.
Int J Obes 2006;30:1585-1594.
131. Follenius M, Brandenberger G, Bardasept J, et al. Nocturnal
cortisol release in relation to sleep structure. Sleep 1992;15:
132. Van Cauter E, van Coevorden A, Blackman JD. Modulation
of neuroendocrine release by sleep and circadian rhythmicity.
In: Yen S, Vale W, editors. Advances in neuroendocrine regulation
of reproduction. Norwell, Mass: Serono Symposia USA; 1990.
p. 113-122.
133. Tasali E, Leproult R, Ehrmann DA, et al. Slow-wave sleep and the
risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A 2008;
134. Bergman RN. Toward physiological understanding of glucose toler-
ance. Minimal model approach. Diabetes 1989;38:1512-1527.
135. Kawakami N, Takatsuka N, Shimizu H. Sleep disturbance and
onset of type 2 diabetes. Diabetes Care 2004;27:282-283.
136. Nilsson PM, Roost M, Engstrom G, et al. Incidence of diabetes in
middle-aged men is related to sleep disturbances. Diabetes Care
137. Meisinger C, Heier M, Loewel H. Sleep disturbance as a predictor
of type 2 diabetes mellitus in men and women from the general
population. Diabetologia 2005;48:235-241.
138. Eriksson AK, Ekbom A, Granath F, et al. Psychological distress and
risk of pre-diabetes and Type 2 diabetes in a prospective study
of Swedish middle-aged men and women. Diabet Med 2008;25:
139. Vgontzas AN, Bixler EO, Lin HM, et al. Chronic insomnia is
associated with nyctohemeral activation of the hypothalamic-pitu-
itary-adrenal axis: clinical implications. J Clin Endocrinol Metab
140. Basta M, Chrousos GP, Vela-Bueno A, et al. Chronic insomnia and
stress system. Sleep Med Clin 2007;2:279-291.
141. Motivala SJ, Tomiyama AJ, Ziegler M, et al. Nocturnal levels of
ghrelin and leptin and sleep in chronic insomnia. Psychoneuroen-
docrinology 2009;34:540-545.
142. Tasali E, Ip MS. Obstructive sleep apnea and metabolic syndrome:
alterations in glucose metabolism and inflammation. Proc Am
Thorac Soc 2008;5:207-217.
143. Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and
type 2 diabetes: interacting epidemics. Chest 2008;133:496-506.
143a. Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK.
Interactions between obesity and obstructive sleep apnea: implica-
tions for treatment. Chest 2010;137(3):711-719.
144. Phillips BG, Kato M, Narkiewicz K, et al. Increases in leptin levels,
sympathetic drive, and weight gain in obstructive sleep apnea. Am
J Physiol Heart Circ Physiol 2000;279:H234-H237.
145. Schmid SM, Hallschmid M, Jauch-Chara K, et al. A single night of
sleep deprivation increases ghrelin levels and feelings of hunger in
normal-weight healthy men. J Sleep Res 2008;17:331-334.
146. Harsch IA, Konturek PC, Koebnick C, et al. Leptin and ghrelin
levels in patients with obstructive sleep apnoea: effect of CPAP
treatment. Eur Respir J 2003;22:251-257.
147. Takahashi K, Chin K, Akamizu T, et al. Acylated ghrelin level in
patients with OSA before and after nasal CPAP treatment. Respirol-
ogy 2008;13:810-816.
148. Loube DI, Loube AA, Erman MK. Continuous positive airway
pressure treatment results in weight less in obese and overweight
patients with obstructive sleep apnea. J Am Diet Assoc 1997;97:
149. Redenius R, Murphy C, O'Neill E, et al. Does CPAP lead to change
in BMI? J Clin Sleep Med 2008;4:205-209.
150. Kajaste S, Brander PE, Telakivi T, et al. A cognitive-behavioral
weight reduction program in the treatment of obstructive sleep
apnea syndrome with or without initial nasal CPAP: a randomized
study. Sleep Med 2004;5:125-131.
151. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal
visceral fat and serum leptin levels in patients with obstructive sleep
apnea syndrome following nasal continuous positive airway pressure
therapy. Circulation 1999;100:706-712.
152. Trenell MI, Ward JA, Yee BJ, et al. Influence of constant positive
airway pressure therapy on lipid storage, muscle metabolism and
insulin action in obese patients with severe obstructive sleep apnoea
syndrome. Diabetes Obes Metab 2007;9:679-687.
153. Vgontzas AN, Zoumakis E, Bixler EO, et al. Selective effects of
CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest
154. Van Cauter E, Leproult R. Sleep and diabesity in older adults. In:
Pandi-Perumal SR, Monti JM, Monjan AA, editors. Principles and
practice of geriatric sleep medicine. Cambridge, UK: Cambridge
University Press; 2009. p. 101-121.
155. Copinschi G, Van Cauter E. Effects of ageing on modulation of
hormonal secretions by sleep and circadian rhythmicity. Hormone
Res 1995;43:20-24.
156. Van Cauter E. Hormones and sleep. In: Kales A, editor. The phar-
macology of sleep. Berlin: Springer Verlag; 1995. p. 279-306.
157. Latta F, Leproult R, Tasali E, et al. Sex differences in nocturnal
growth hormone and prolactin secretion in healthy older adults:
relationships with sleep EEG variables. Sleep 2005;28:1519-
158. Van Cauter E, Leproult R, Plat L. Age-related changes in slow wave
sleep and REM sleep and relationship with growth hormone and
cortisol levels in healthy men. JAMA 2000;284:861-868.
159. Prinz P, Moe K, Dulberg E, et al. Higher plasma IGF-1 levels are
associated with increased delta sleep in healthy older men. J Geron-
tol 1995;50A:M222-M226.
160. van Coevorden A, Mockel J, Laurent E, et al. Neuroendocrine
rhythms and sleep in aging men. Am J Physiol 1991;260:E651-
161. Van Cauter E, Leproult R, Kupfer DJ. Effects of gender and age
on the levels and circadian rhythmicity of plasma cortisol. J Clin
Endocrinol Metab 1996;81:2468-2473.
162. Penev PD. Association between sleep and morning testosterone
levels in older men. Sleep 2007;30:427-432.
163. Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered
breathing. J Appl Physiol 2005;99:1592-1599.
164. Vgontzas AN, Bixler EO, Tan TL, et al. Obesity without sleep
apnea is associated with daytime sleepiness. Arch Intern Med
165. Vgontzas AN, Tan TL, Bixler EO, et al. Sleep apnea and sleep
disruption in obese patients. Arch Internal Med 1994;154:1705-
166. Resta O, Foschino Barbaro MP, Bonfitto P, et al. Low sleep quality
and daytime sleepiness in obese patients without obstructive sleep
apnoea syndrome. J Intern Med 2003;253:536-543.
167. Resta O, Foschino-Barbaro MP, Legari G, et al. Sleep-related
breathing disorders, loud snoring and excessive daytime sleepiness
in obese subjects. Int J Obes Relat Metab Disord 2001;25:
168. Vgontzas AN, Bixler EO, Chrousos GP. Obesity-related sleepiness
and fatigue: the role of the stress system and cytokines. Ann N Y
Acad Sci 2006;1083:329-344.
169. Vgontzas AN, Lin HM, Papaliaga M, et al. Short sleep duration
and obesity: the role of emotional stress and sleep disturbances. Int
J Obes 2008;32:801-809.
Search Pocayo ::

Custom Search